4 results on '"Mereu, Maddalena"'
Search Results
2. The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.
- Author
-
Mereu, Maddalena, Chun, Lauren E., Prisinzano, Thomas E., Newman, Amy H., Katz, Jonathan L., Tanda, Gianluigi, and Bolam, Paul
- Subjects
- *
MODAFINIL , *NEUROCHEMISTRY , *MICRODIALYSIS , *COCAINE , *LABORATORY mice , *PHYSIOLOGY - Abstract
Blockade of dopamine ( DA) reuptake via the dopamine transporter ( DAT) is a primary mechanism identified as underlying the therapeutic actions of (±)-modafinil (modafinil) and its R-enantiomer, armodafinil. Herein, we explored the neurochemical and behavioral actions of modafinil to better characterize its psychostimulant profile. Swiss-Webster mice were implanted with microdialysis probes in the nucleus accumbens shell ( NAS) or core ( NAC) to evaluate changes in DA levels related to acute reinforcing actions of drugs of abuse. Additionally, subjective effects were studied in mice trained to discriminate 10 mg/kg cocaine (i.p.) from saline. Modafinil (17-300 mg/kg, i.p.) significantly increased NAS and NAC DA levels that at the highest doses reached ~300% at 1 h, and lasted > 6 h in duration. These elevated DA levels did not show statistically significant regional differences between the NAS and NAC. Modafinil produced cocaine-like subjective effects at 56-100 mg/kg when administered at 5 and 60 min before the start of the session, and enhanced cocaine effects when the two were administered in combination. Despite sharing subjective effects with cocaine, modafinil's psychostimulant profile was unique compared to that of cocaine and like compounds. Modafinil had lower potency and efficacy than cocaine in stimulating NAS DA. In addition, the cocaine-like subjective effects of modafinil were obtained at lower doses and earlier onset times than expected based on its dopaminergic effects. These studies suggest that although inhibition of DA reuptake may be a primary mechanism underlying modafinil's therapeutic actions, non DA-dependent actions may be playing a role in its psychostimulant profile. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Dopamine–mediated immunomodulation affects choroid plexus function.
- Author
-
Castellani, Giulia, Contarini, Gabriella, Mereu, Maddalena, Albanesi, Ennio, Devroye, Céline, D'Amore, Claudio, Ferretti, Valentina, De Martin, Sara, and Papaleo, Francesco
- Subjects
- *
CHOROID plexus , *IMMUNOREGULATION , *IMMUNE system , *IMMUNOLOGICAL tolerance , *IMMUNOPHENOTYPING - Abstract
• DAT genetic hypofunction results in a general immunotolerance. • Amphetamine exposure produce a general immunotolerance. • DAT-by-amphetamine interaction aberrantly modulates the choroid plexus gateway. Immune system alterations have been implicated in various dopamine-related disorders, such as schizophrenia, bipolar disorder, and attention-deficit/hyperactivity disorder (ADHD). How immunity might be influenced by dopaminergic dysfunction and impact on clinically-relevant behaviors is still uncertain. We performed a peripheral and cerebral immunophenotyping in mice bearing dopaminergic alteration produced by genetic liability (hypofunction of the dopamine transporter DAT) and psychostimulant (amphetamine) administration. We found that DAT hypofunction influences immune tolerance by increasing functional Tregs and adrenomedullin levels in the thymus and spleen, while reducing microglia activation and infiltration of brain monocyte-derived macrophages (mo-MΦ). Remarkably, both DAT hypofunction and amphetamine treatment are associated with a weaker activation of the choroid plexus (CP) gateway. Conversely, amphetamine reactivated the CP in the setting of DAT hypofunction, paralleling its paradoxical ADHD-relevant behavioral effects. These findings add new knowledge on dopaminergic immunopharmacology and support the immunomodulation of CP functionality as a promising therapeutic strategy for neurodevelopmental and psychiatric disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Preference for Distinct Functional Conformations of the Dopamine Transporter Alters the Relationship between Subjective Effects of Cocaine and Stimulation of Mesolimbic Dopamine.
- Author
-
Kohut, Stephen J., Hiranita, Takato, Hong, Soo-Kyung, Ebbs, Aaron L., Tronci, Valeria, Green, Jennifer, Garcés-Ramírez, Linda, Chun, Lauren E., Mereu, Maddalena, Newman, Amy H., Katz, Jonathan L., and Tanda, Gianluigi
- Subjects
- *
DOPAMINE uptake inhibitors , *COCAINE abuse , *MICRODIALYSIS , *NUCLEUS accumbens , *ATTENTION-deficit hyperactivity disorder , *NEUROBEHAVIORAL disorders , *THERAPEUTICS - Abstract
Background Subjective effects of cocaine are mediated primarily by dopamine (DA) transporter (DAT) blockade. The present study assessed the hypothesis that different DAT conformational equilibria regulate differences in cocaine-like subjective effects and extracellular DA induced by diverse DA-uptake inhibitors (DUIs). Methods The relationship between cocaine-like subjective effects and stimulation of mesolimbic DA levels by standard DUIs (cocaine, methylphenidate, WIN35,428) and atypical DUIs (benztropine analogs: AHN1-055, AHN2-005, JHW007) was investigated using cocaine discrimination and DA microdialysis procedures in rats. Results All drugs stimulated DA levels with different maxima and time courses. Standard DUIs, which preferentially bind outward-facing DAT conformations, fully substituted for cocaine, consistently producing cocaine-like subjective effects at DA levels of 100–125% over basal values, regardless of dose or pretreatment time. The atypical DUIs, with DAT binding minimally affected by DAT conformation, produced inconsistent cocaine-like subjective effects. Full effects were obtained, if at all, only at a few doses and pretreatment times and at DA levels 600–700% greater than basal values. Importantly, the linear, time-independent, relationship between cocaine-like subjective effects and DA stimulation obtained with standard DUIs was not obtained with the atypical DUIs. Conclusions These results suggest a time-related desensitization process underlying the reduced cocaine subjective effects of atypical DUIs that may be differentially induced by the binding modalities identified using molecular approaches. Since the DAT is the target of several drugs for treating neuropsychiatric disorders, such as attention-deficit/hyperactivity disorder, these results help to identify safe and effective medications with minimal cocaine-like subjective effects that contribute to abuse liability. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.